Sms Pharmaceuticals [SMSPHARMA] vs Sanofi India Limited [SANOFI] Detailed Stock Comparison
Sms Pharmaceuticals
NSE
Loading...
Sanofi India Limited
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Sms Pharmaceuticals wins in 5 metrics, Sanofi India Limited wins in 15 metrics, with 0 ties. Sanofi India Limited appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sms Pharmaceuticals | Sanofi India Limited | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 27.12 | 32.51 | Sms Pharmaceuticals |
| Price-to-Book Ratio | 3.20 | 15.05 | Sms Pharmaceuticals |
| Debt-to-Equity Ratio | 48.58 | 2.67 | Sanofi India Limited |
| PEG Ratio | 1.47 | -1.00 | Sanofi India Limited |
| EV/EBITDA | 16.08 | 22.96 | Sms Pharmaceuticals |
| Profit Margin (TTM) | 8.98% | 18.29% | Sanofi India Limited |
| Operating Margin (TTM) | 15.11% | 21.12% | Sanofi India Limited |
| EBITDA Margin (TTM) | 15.11% | 21.12% | Sanofi India Limited |
| Return on Equity | 10.81% | 49.43% | Sanofi India Limited |
| Return on Assets (TTM) | 6.00% | 22.47% | Sanofi India Limited |
| Free Cash Flow (TTM) | $-416.71M | $4.25B | Sanofi India Limited |
| Dividend Yield | 0.16% | 1.93% | Sanofi India Limited |
| 1-Year Return | -33.35% | -24.95% | Sanofi India Limited |
| Price-to-Sales Ratio (TTM) | 2.52 | 5.94 | Sms Pharmaceuticals |
| Enterprise Value | $23.21B | $114.62B | Sanofi India Limited |
| EV/Revenue Ratio | 2.85 | 5.79 | Sms Pharmaceuticals |
| Gross Profit Margin (TTM) | 33.33% | 48.63% | Sanofi India Limited |
| Revenue per Share (TTM) | $95 | $860 | Sanofi India Limited |
| Earnings per Share (Diluted) | $8.52 | $157.20 | Sanofi India Limited |
| Beta (Stock Volatility) | 0.56 | 0.08 | Sanofi India Limited |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Sms Pharmaceuticals vs Sanofi India Limited Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sms Pharmaceuticals | 4.91% | -7.72% | -7.65% | -17.39% | 15.83% | -13.41% |
| Sanofi India Limited | 0.67% | -3.19% | -11.88% | -17.82% | 1.82% | -16.17% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sms Pharmaceuticals | -33.35% | 178.21% | 164.52% | 334.17% | 1,080.19% | 589.16% |
| Sanofi India Limited | -24.95% | -16.54% | -39.22% | 31.24% | 183.72% | 244.79% |
Performance & Financial Health Analysis: Sms Pharmaceuticals vs Sanofi India Limited
| Metric | SMSPHARMA | SANOFI |
|---|---|---|
| Market Information | ||
| Market Cap | ₹20.49B | ₹117.69B |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 40,105 | 11,669 |
| 90 Day Avg. Volume | 70,958 | 11,166 |
| Last Close | ₹236.85 | ₹5,144.00 |
| 52 Week Range | ₹176.05 - ₹398.00 | ₹4,902.00 - ₹7,600.00 |
| % from 52W High | -40.49% | -32.32% |
| All-Time High | ₹398.00 (Sep 23, 2024) | ₹10,524.95 (Jun 10, 2024) |
| % from All-Time High | -40.49% | -51.13% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.19% | -0.12% |
| Quarterly Earnings Growth | 0.24% | -0.33% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.18% |
| Operating Margin (TTM) | 0.15% | 0.21% |
| Return on Equity (TTM) | 0.11% | 0.49% |
| Debt to Equity (MRQ) | 48.58 | 2.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹72.15 | ₹339.62 |
| Cash per Share (MRQ) | ₹4.69 | ₹135.75 |
| Operating Cash Flow (TTM) | ₹1.03B | ₹3.90B |
| Levered Free Cash Flow (TTM) | ₹691.35M | ₹2.49B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.16% | 1.93% |
| Last 12-Month Dividend | ₹0.40 | ₹117.00 |
Valuation & Enterprise Metrics Analysis: Sms Pharmaceuticals vs Sanofi India Limited
| Metric | SMSPHARMA | SANOFI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 27.12 | 32.51 |
| Forward P/E | N/A | 25.08 |
| PEG Ratio | 1.47 | -1.00 |
| Price to Sales (TTM) | 2.52 | 5.94 |
| Price to Book (MRQ) | 3.20 | 15.05 |
| Market Capitalization | ||
| Market Capitalization | ₹20.49B | ₹117.69B |
| Enterprise Value | ₹23.21B | ₹114.62B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.85 | 5.79 |
| Enterprise to EBITDA | 16.08 | 22.96 |
| Risk & Other Metrics | ||
| Beta | 0.56 | 0.08 |
| Book Value per Share (MRQ) | ₹72.15 | ₹339.62 |
Financial Statements Comparison: Sms Pharmaceuticals vs Sanofi India Limited
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SMSPHARMA | SANOFI |
|---|---|---|
| Revenue/Sales | ₹1.96B | ₹5.36B |
| Cost of Goods Sold | ₹1.31B | ₹2.41B |
| Gross Profit | ₹653.49M | ₹2.95B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹296.17M | ₹1.62B |
| EBITDA | ₹399.62M | ₹1.75B |
| Pre-Tax Income | ₹243.69M | ₹1.65B |
| Income Tax | ₹56.54M | ₹458.00M |
| Net Income (Profit) | ₹204.91M | ₹1.20B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SMSPHARMA | SANOFI |
|---|---|---|
| Cash & Equivalents | ₹413.99M | ₹2.84B |
| Total Current Assets | ₹5.54B | ₹11.27B |
| Total Current Liabilities | ₹3.24B | ₹7.19B |
| Long-Term Debt | ₹1.39B | ₹140.00M |
| Total Shareholders Equity | ₹6.40B | ₹8.61B |
| Retained Earnings | N/A | ₹4.46B |
| Property, Plant & Equipment | ₹5.31B | ₹3.11B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SMSPHARMA | SANOFI |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SMSPHARMA | SANOFI |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 40,105 | 11,669 |
| Average Daily Volume (90 Day) | 70,958 | 11,166 |
| Shares Outstanding | 88.65M | 23.03M |
| Float Shares | 45.35M | 9.07M |
| % Held by Insiders | 0.74% | 0.61% |
| % Held by Institutions | 0.02% | 0.26% |
Dividend Analysis & Yield Comparison: Sms Pharmaceuticals vs Sanofi India Limited
| Metric | SMSPHARMA | SANOFI |
|---|---|---|
| Last 12-Month Dividend | ₹0.40 | ₹117.00 |
| Last 12-Month Dividend Yield | 0.16% | 1.93% |
| 3-Year Avg Annual Dividend | ₹0.33 | ₹220.00 |
| 3-Year Avg Dividend Yield | 0.23% | 2.07% |
| 3-Year Total Dividends | ₹1.00 | ₹660.00 |
| Ex-Dividend Date | Sep 23, 2024 | Apr 25, 2025 |